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Background: Metagenomics has become a prominent approach for exploring the role of the gut microbiota in
human health. However, the temporal variability of the healthy gut microbiome has not yet been studied in depth
using metagenomics and little is known about the effects of different sampling and preservation approaches. We
performed metagenomic analysis on fecal samples from seven subjects collected over a period of up to two years
to investigate temporal variability and assess preservation-induced variation, specifically, fresh frozen compared to
RNALater. We also monitored short-term disturbances caused by antibiotic treatment and bowel cleansing in
one subject.
Results: We find that the human gut microbiome is temporally stable and highly personalized at both taxonomic
and functional levels. Over multiple time points, samples from the same subject clustered together, even in the context
of a large dataset of 888 European and American fecal metagenomes. One exception was observed in an antibiotic
intervention case where, more than one year after the treatment, samples did not resemble the pre-treatment state.
Clustering was not affected by the preservation method. No species differed significantly in abundance, and only
0.36% of gene families were differentially abundant between preservation methods.
Conclusions: Technical variability is small compared to the temporal variability of an unperturbed gut microbiome,
which in turn is much smaller than the observed between-subject variability. Thus, short-term preservation of fecal
samples in RNALater is an appropriate and cost-effective alternative to freezing of fecal samples for metagenomic
studies.Background
Microbial communities that inhabit the human gut are
essential to human health. To better understand the role
of gut microbes in health, major efforts have been
undertaken including large-scale studies such as the
European Metagenomics of the Human Intestinal Tract
(MetaHIT) project and the US American Human Micro-
biome Project (HMP) [1,2]. These studies have provided
insights into the gut microbial community composition
in healthy human individuals. Changes in the microbial
community composition have been associated with diet
[3,4] as well as with multiple diseases, such as athero-
sclerosis, inflammatory bowel diseases and obesity [5-7].* Correspondence: bork@embl.de
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unless otherwise stated.In addition to these cross-sectional studies that com-
pared healthy and diseased cohorts, longitudinal studies
have helped shed light not only on the community com-
positional variability but also on the temporal variability,
providing a more complete picture of the factors that
shape the gut microbiome in health and disease. Several
studies have demonstrated considerable between-subject
variability of the gut microbial composition. However,
the gut microbiome has been described to be con-
strained around a highly personal and stable compo-
sition within each healthy subject over time [8-12].
Perturbation of the human gut microbiome is known
to occur as a result of antibiotics treatment, a frequently
prescribed medication. Antibiotic intervention leads to a
rapid decrease of diversity and post-treatment recovery
is slow and incomplete, even up to 4 years after the
treatment [13-17]. Resistant bacterial species, as a resulthis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Voigt et al. Genome Biology  (2015) 16:73 Page 2 of 12of antibiotics treatment, can persist over years [18-20]
and the resistance potential of gut microbiota displays re-
gional differences [21,22]. Similarly, there are indications
of other long-term community shifts caused by endo-
genous (for example, disease) or environmental perturba-
tions (for example, diet and lifestyle change [3,4,23]) that
have not yet been studied in depth.
Studies on the temporal variability of the gut micro-
biome have mostly been performed over short periods
(weeks to one year; for example, [8,12,23,24]) and only
rarely over long periods (5 and 12 years [9,11]). The
methods of deriving the taxonomic community compo-
sition were primarily based on PCR-denaturing gradient
gel electrophoresis (PCR-DGGE; for example, [25]), 16S
rRNA gene sequencing (for example, [26,27]), and the
HITChip microarray (for example, [11,28]). Only two
studies [12,29] have so far analyzed longitudinal non-
amplified metagenomic shotgun sequencing data that
were collected from 43 subjects in the context of the
HMP [1]. However, the majority (41 out of 43) were only
sampled twice, making it difficult to assess temporal
stability.
Despite their common aim to better understand micro-
bial community shifts over time, the aforementioned
studies do not attempt to quantify different sources of
variability, from technical to biological ones. In particular,
technical aspects have been shown to be important for the
comparison between data sets. Limited comparability in
human microbiome data sets often results from dif-
ferences in sample preservation and DNA isolation proto-
cols as well as readout methods (for example, sequencing
of different 16S rRNA gene regions or application of
different sequencing technologies). A meta-analysis [30]
assessing the effect size of technical differences on data
comparability showed that samples rather cluster by study
or the methods applied (for example, for DNA isolation)
than by the parameter of interest (for example, disease
state). To counteract these batch effects, the International
Human Microbiome Standards (IHMS) project was
launched to suggest standards for sample processing
(mainly DNA isolation) with the goal to maximize
future data comparability. However, different storage
conditions of a fecal sample can also impact the compo-
sitional readout, as different microbes respond differently
to environmental exposure [31]. Research in this direction
has been conducted previously to compare different stor-
age and preservation conditions (for example, different
temperatures or preservatives such as RNALater) [32,33].
RNALater, a quaternary ammonium salts-based solution,
is commonly used as a logistically convenient solution to
preserve RNA from biological samples at room tempe-
rature when freezing is not possible, and was recently also
considered for omics technologies [34]. It was shown to
have a minor effect on the recovered composition andthus represents a potential alternative to immediate
freezing [35-37]. To date, the technical variability on a taxo-
nomic and functional level has not been put in the context
of temporal and within-sample variability (meaning within
the stool from a single bowel movement).
We collected fecal samples over up to two years from
seven subjects to investigate the temporal variability and
individuality of the human gut microbiome using meta-
genomic shotgun sequencing. To disentangle technical,
temporal and between-subject variability we contrasted
the variability of microbial community composition
within a fecal sample [38,39] with the variability intro-
duced by different preservation methods, RNALater or
freezing after two different time intervals. By comparing
the fecal metagenomes of the seven subjects over time
and in the context of 888 published metagenomes, we
generally found between-subject variability to be much
larger than within-subject variability. This high degree of
individuality can, however, be disrupted by antibiotic
treatment, which in one subject triggered a large and long-
lasting community shift. Bowel cleanse was also investi-
gated but did not appear to cause a major disturbance.
Technical variability (within-sample and preservation-
induced variability) was smaller than temporal within-
subject variability and therefore we propose RNALater as
an alternative to fresh freezing fecal samples.Results and discussion
Study design
Fecal samples were self-collected from seven adults at
short (few days) and longer (weeks to months) time in-
tervals (Additional file 1). All subjects were considered
healthy at the time of sampling, unless stated otherwise
(see Material and methods). The study was split into five
sub-studies as shown in Figure 1. Out of the seven sub-
jects, five subjects performed sampling for more than
one year while three subjects collected over more than
two years (sub-study 3). At two time points, seven days
(d7; sub-study 1) and 392 days (d392; sub-study 2) after
the first sampling event, feces from three and five sub-
jects, respectively, were collected and replicates either
frozen or preserved in RNALater. One subject (Alien)
collected additional fecal samples after antibiotics treat-
ment (d376–380, sub-study 4) and bowel cleanse (d630–637,
sub-study 5).
All fecal samples were subjected to whole genome shot-
gun sequencing and the data analyzed at species-level
using mOTUs (metagenomic operational taxonomic units
based on single-copy phylogenetic marker genes [29]),
and at a number of functional levels: clusters of ortholo-
gous groups (COGs) [40], KEGG (Kyoto Encyclopedia of
Genes and Genomes) groups of orthologous genes (KOs),
modules and pathways [41].
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Figure 1 Overview of the study design. This variability assessment was subdivided into five sub-studies. The comparison of technical variability
due to fecal preservation methods and stool homogeneity was addressed in sub-studies 1 and 2, respectively. The conditions for the different
preservation methods and the numbers of replicates taken are described for these sub-studies. Sub-study 3 was about the temporal variability
within and between subjects. One subject underwent antibiotics treatment (sub-study 4) and bowel cleanse (sub-study 5) in the time course of
the study. The sampling time points and number of subjects that collected fecal samples are indicated in the timeline.
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Biological samples are generally stored frozen or pro-
cessed immediately to maintain their integrity. However,
this is often logistically inconvenient, especially in remote
areas. In contrast, preservation in RNALater eliminates
the need for immediate freezing or sample processing.
RNALater is an aqueous solution that preserves biological
samples by protecting especially RNA from degradation
(for example, [42]). The solution penetrates and stabilizes
the sample for later analysis. According to the manu-
facturer’s instruction, these samples are stable at room
temperature (RT) for up to one week, at +4°C for one
month and at −20°C and −80°C indefinitely. Thus, the
usage of RNALater for sample collection would facilitate
sample preservation and shipping prior to metagenomic
analysis.
We collected fresh samples from which aliquots were
frozen immediately (to be used as reference samples)
or preserved in RNALater. At d7, RNALater-preserved
samples from five subjects were kept at both +4 to 10°C
and RT for one week. However, at d392 RNALater-
preserved samples were kept at +4°C for 24 h from threesubjects before storing at −80°C (sub-studies 1 and 2;
Figure 1).
To analyze the taxonomic variability of frozen and
RNALater-preserved replicates, we performed hierar-
chical clustering of the mOTU abundances based on
Euclidean distance. This analysis revealed that samples
from the same subject clustered together irrespective of
the preservation method. This similarity held true for
both d7 and d392 with the exception of subject Alien,
who underwent an antibiotics treatment in between
these time points (Figures 2A,B and 3A). Within the
cluster of each subject (at d392), the replicates did not
cluster by the preservation protocol (Figure 2B), sugges-
ting that biological within-sample variability was larger
than preservation-induced effects.
To extend this observation, we clustered all collected
samples from all subjects in the context of 888 published
metagenomes from MetaHIT and HMP (Figure 4; details
in Material and methods). We found that the samples
from d7 and d392 had other samples from the same sub-
ject as nearest neighbors. All d7 samples had the other
two replicates from d7 as nearest neighbors (Figure 4).
For d392, the first three Peacemaker and four Bugkiller
Figure 2 Comparison of methods for fecal sampling. (A,B) The samples collected in sub-studies 1 (d7) and 2 (d392) clustered by subject (A) and
time point (B) but not according to the preservation method (frozen, RNALater (+4 to 10°C or RT for 1 week (1w) on d7; frozen and RNALater +4°C,
24 h on d392) applied (complete linkage clustering based on Euclidean distance). (C) Shannon diversity index, richness and evenness are shown for d7
(upper panels) and d392 (lower panels) and statistically significant differences are indicated by asterisks with P-value ≤0.05 (unpaired Wilcoxon test).
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For subject Alien, all samples from d392 clustered to-
gether but the nearest neighbor was not necessarily the
samples preserved under the same condition. Thus, the
samples did not cluster by preservation method. Taken
together, these results show that RNALater does not
introduce a bias in the overall microbiome composition
and its effect is smaller than within-subject variability.
We repeated the taxonomic analyses using gene abun-
dances summarized at different functional levels. Rela-
tive abundance of orthologous groups, that is, COG and
KO profiles, (see Material and methods) of all collected
samples were clustered in the context of 888 published
metagenomes from MetaHIT and HMP (Additional files
2 and 3). For both COG and KO profiles, the nearest
neighbor of samples from d7 and d392 were very similar
to those seen in taxonomic clustering (Figure 4). Using
COG abundances, with the exception of one Peacemaker
sample, all d7 replicates clustered together, and for
Peacemaker and Alien four and five of the d392 sample
replicates, respectively, clustered together. Using KO
profiles, the clustering of samples was similar.
To get a deeper insight into potential preservation-
induced changes of the microbiome, we compared indi-
ces for species diversity and community evenness. At d7,
RNALater-preserved samples (storage at RT or at +4 to
10°C) compared to the immediately frozen samples
showed a significant decrease in their Shannon diversityindex (P = 0.016 and P = 0.0008, unpaired Wilcoxon-test)
and species evenness (P = 0.016 and P = 0.016, unpaired
Wilcoxon-test) but not richness (P = 0.056 and P = 0.056,
unpaired Wilcoxon-test). In contrast, at d392, RNALater
preservation did not have the same effect on these eco-
logical indices (Figure 2C).
To determine preservation-induced and temporal within-
subject and between-subject differences, we correlated
mOTU, COGs, KOs, KEGG modules and pathways
(Spearman correlation) between different preservation
techniques, sampling time points and subjects (Figure 3A,B;
Figure S3A-C in Additional file 4). We found that the
similarity between protocols is consistently high for both
species and COGs (minimum Spearman’s r = 0.82 and
0.95, respectively), similar to previous findings [36]. Due
to our longitudinal study design we could extend the
analysis performed by Franzosa et al. [36], and verify that
the correlation between time points was lower for both
species and COGs (maximum Spearman’s r = 0.75 and 0.93,
respectively) than between preservation methods. Between-
subject correlations were even lower than between-time
point correlations.
To estimate differences in taxonomic (species) and func-
tional (eggNOG COGs, and KEGG KOs, modules and
pathways) composition between frozen and RNALater-
preserved samples from d7 and d392, we performed two-
way ANOVA testing on both the taxonomic and functional
relative abundances (see Material and methods). We
Figure 3 Comparison of technical, temporal within-subject and between-subject variability at taxonomic and functional levels. (A,B) Spearman’s
rank correlations of species profiles (A) and cluster of orthologous groups (COG) profiles (B) were highly correlated between different preservation
methods (frozen versus RNALater (+4 to 10°C or RT for 1 week (1w) each), RNALater at +4 to 10°C versus RNALater at RT and frozen versus
RNALater at +4°C, 24 h), less correlated between sampling time points (d7 versus d392), with lower correlation seen between subjects. Black bars
represent group-wise medians. Relatively lower correlation between time points was apparent for the Alien samples (red squares), which were taken
before and after antibiotics treatment (see main text). (C,D) Preservation-induced changes relative to between-subject variability was quantified by
two-way ANOVA for species (C) and COGs (D), including only features with a relative abundance of at least 0.01% in three or more samples. In total,
7.3% and 5.33% of species and COGs, respectively, showed greater between-method variation than between-subject variation (features above the
horizontal black line), but this was statistically significant for only 0.36% of COGs and none of the species tested (Benjamini-Hochberg false discovery
rate, α = 0.05, Additional file 5). Vertical blue and green lines represent the threshold for statistical significance for d7 and d392, respectively. Percentages
left and right of these lines identify the fractions of statistically significant and insignificant features with larger between-protocol variation for each time
point, respectively.
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relative abundance exceeding 0.01% in at least 3 of the 33
tested samples varied more between preservation methods
than between subjects. However, none of these were sta-
tistically significant after correction for multiple hypoth-
esis testing (Benjamin-Hochberg α = 0.05; Figure 3C;
Additional file 5). For d7 and d392, 0.77% and 4.2% of the
COGs, respectively, varied more between the preservation
methods than between subjects, but only 0.36% of COGs
were statistically significant (Figure 3D; Additional file 5),
which is in the range of previous findings [36]. We found
that 0.72%, 0% and 0% of the KOs, modules and pathways,
respectively, varied more between preservation methods
than between subjects (Figure S3D-F in Additional file 4).In summary, RNALater appears, in line with a pre-
vious publication [36], to be a suitable alternative to im-
mediate freezing at least for short-term storage of a few
days, as the variability between protocol replicates is
lower than that between time points of the same subject
and between subjects.
Within-sample variability of the fecal species community
It was previously shown that there is considerable spatial
within-sample variation of parasites in human feces [38]
and low abundant bacteria were only sporadically de-
tected in all replicates of the same sample [39]. To ad-
dress within-sample and technical reproducibility in our
study, triplicates at distinct sites of the same fecal
Figure 4 Nearest neighbor plot. The mOTU abundances of the fecal metagenomes of the time series and replicates were clustered in the
context of 888 published metagenomes. Only the 14 nearest neighbors (NN) are shown for visual clarity. The colored boxes indicate the
respective subject. Non-self samples (samples from another subject, including HMP and MetaHIT) are shaded in grey. Subjects are color-coded,
sampling time points are indicated and text color corresponds to the preservation condition of each sample (see key). The column on the right
shows how many NNs of each respective sample are depicted, indicating the subject-specificity of the clustering (complete linkage clustering
based on Euclidean distances). The figure shows that, with very few exceptions, all time series samples and all fecal replicates (from d7 and d392)
from one subject were closer to each other than to any other sample from another subject. Pre-treatment samples from subject Alien were nearest
neighbors to each other while the samples right after the treatment (d376–380) had highest similarity to each other but not to the pre-treatment
samples. The samples collected long after the treatment (d600–773) were most similar to each other but a slow recovery to the pre-antibiotics state was
visible since pre-treatment samples are among the 14 neighbors shown.
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two preservation protocols (RNALater and freezing;
Figure 1, sub-study 2).
For two subjects the replicates showed only minor
variation in ecological indices (Shannon diversity index,
species richness and community evenness). Larger fluc-
tuations were detected for diversity and evenness of
fresh frozen samples from subject Bugkiller only (Figure 2C,
lower panel). Nevertheless, all replicates clustered by sub-
ject (including Bugkiller) in the context of the samples col-
lected on d392 (Figure 2B). To set within-sample variation
in the context of all time series samples and the MetaHIT
and HMP samples (N = 888), we clustered all samples to-
gether (Figure 4). The replicates from all three subjectshad the other replicates from the same subject as nearest
neighbors. All replicates from subject Alien clustered by
d392 but not with the pre-/post-treatment samples,
highlighting the drastic change introduced by the treat-
ment. These results for Alien remained the same when
clustering based on abundances of functional categories
(Additional files 2 and 3). This implies that subject-
specificity and community similarity is high for all
replicates of a fecal sample with only minor fluctuations
in diversity and evenness. Together with the fact that rep-
licates preserved under different conditions did not cluster
by preservation method (Figures 2B and 4) this supports
our study design which was based on samples that were
deliberately not homogenized before aliquoting since
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participants and usually not homogenized in large metage-
nomic studies and (ii) we aimed to assess within-sample
variability.
Temporal variability of fecal microbial communities
In order to assess how technical variability compares to
temporal variability, all samples collected by the seven
subjects were clustered. It showed that the temporal
variability was small and the samples clustered by sub-
ject except for Alien (Figure 5A,B). Omitting all samples
taken from Alien after antibiotics treatment resulted in
consistent clustering by subject (Figure 5C), showing
high subject-specificity and individuality of the gut mi-
crobiome. In order to test whether the individuality of
the gut microbiome persists on the background of 888
published metagenomes from MetaHIT and HMP, we
clustered them together and show the nearest neighbors
in Figure 4. The time series samples from the seven sub-
jects were closest to other samples from the same sub-
ject rather than to another subject. This was also seen
for the 43 subjects in the HMP study, which have mul-
tiple time-points. Only few samples from our dataset
had the sample of another subject as closer neighbor
than a time series sample when comparing the relative
taxonomic abundances. For example, the d392 sample
from Scavenger has a sample from another subject as
fifth neighbor instead of the Scavenger d0 sample. TheFigure 5 Clustering of the complete time series data set. (A) The unpertur
samples, which showed a decline of the Shannon diversity index upon ant
no detectable effect. The separation of the post-antibiotics from the pre-an
Jensen-Shannon divergence distances was significantly correlated with the
(A, lower panel) and explained the separate clustering of pre-and post-trea
microbiome was highly personal and when omitting the post-antibiotics sa
years can be resolved.number of samples having another subject as closer
neighbor rather than a time series sample from the same
subject increased when clustering was performed using
relative COG and KO abundances (Additional files 2
and 3).
To characterize the temporal variability of the commu-
nity structure, we calculated the ecological indices, such
as the Shannon diversity index, and found that they
varied little over time for all subjects (Figure 5A, lower
panel for diversity) except Alien, who underwent anti-
biotics treatment.
Our results support previous studies reporting that the
temporal variability of the species composition within a
subject is smaller than between-subject variability and
that in the absence of larger perturbation each indi-
vidual’s microbiota remains relatively stable over time
[6,8,9,11,12,14,24,26-29]. However, here we show that
even in the context of a large cohort of fecal metage-
nomes the subjects can be resolved based on the taxo-
nomic composition of their fecal metagenomes with very
few exceptions. Thus, the gut microbiome, if unper-
turbed, is highly subject-specific and the variability is
small compared to the between-subject variability.
The effect of perturbations on fecal microbial
communities
During the time period of the study, one subject (Alien)
suffered from an infection that was treated with antibioticsbed microbiomes of the subjects were stable except for the Alien
ibiotics treatment (d376–392) while the bowel cleanse (d630–637) had
tibiotics samples along the first principal coordinate (PC1) based on
decline of the Shannon diversity index (dotted line, P-value = 3.9e−14)
tment samples (A, upper panel and (B)). (C) The unperturbed gut
mples, all subjects that collected time series samples over up to two
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bowel cleanse. The antibiotics treatment comprised four
days with ceftriaxone, a third-generation cephalosporin
antibiotic with broad-spectrum activity against Gram-
positive and Gram-negative bacteria. To investigate the
consequences of these medical treatments, additional
samples were collected for this subject after antibiotics in-
take (d376, d377 and d380) and bowel cleanse (d630, d632,
and d637) (Figure 1, sub-studies 4 and 5; for further details
see Material and methods).
To observe the response of the fecal microbiome to these
two perturbations, we performed hierarchical clustering
and found that the post-antibiotics samples separated from
the pre-antibiotics samples, but were still distinct from
other subjects (Figure 5A,B). The samples taken 226 to
399 days after antibiotics treatment (d600–773) clustered
closer to the pre-treatment samples (Figure 5A,B), sug-
gesting a (partial) recovery. Determining the nearest
neighbor samples in the context of the 888 HMP and
MetaHIT samples, using Euclidean distance on taxonomic
and functional profiles, confirmed the aforementioned ob-
servation suggesting that the gut community composition
was still distinct even 399 days (d773) post-antibiotics
treatment but gained similarity with the pre-antibiotics
community composition (Figure 4). A similar pattern was
observed for nearest-neighbor analysis of COG abun-
dances, but individual specificity was less clear for KO
abundances (Additional files 2 and 3).
The immediate post-treatment samples (d376–380)
showed a drastic reduction in Shannon diversity index,
species richness and evenness, indicating that fewer and
less evenly abundant microbial species were detected.
The Shannon diversity index, species richness and even-
ness of the post-treatment samples dropped from 3.5 to
0.2, 100 to 37 and 0.75 to 0.05, respectively, and were
still reduced at d392 (18 days after the treatment), com-
pared to the pre-treatment state. At d600, the diversity
had returned to its initial level (Figure 5A, lower panel),
yet the samples still clustered separately from the pre-
treatment samples, indicating that the recovery is not
complete (Figures 4 and 5B). Separation of community
profiles from the initial state along the first principal co-
ordinate in an ordination analysis (using Jensen-Shannon
divergence) correlated with the decline of the Shannon
diversity index (Pearson correlation rho = 0.86, P = 3.9e−14;
Figure 5A).
The bowel cleanse on the day before d630 did not have
a considerable effect on the community composition:
the samples cluster closely with d600, which was before
colonoscopy and the fluctuation of the Shannon diver-
sity index was similar to the other subjects and notably
smaller than the impact of the antibiotics treatment
(Figure 5A,B). Although this case study comprises only
one subject, our result that bowel cleanse has little effecton gut microbiome composition is in line with the find-
ing by O’Brien et al. [43].
It has been reported that antibiotics have a strong im-
pact on the gut microbial community composition for
an extended period of time, although the community
was sometimes found to be similar to its pretreatment
state within weeks. The return was subject-dependent
and often incomplete, at least for some species moni-
tored for time periods of two to six months [14,17] and
up to two years [19,44]. Even though we studied the ef-
fect of antibiotics in only one subject, we can show that,
at least in this subject, despite species diversity recovery,
the gut microbial composition was still distinct from the
pre-treatment state, even 399 days after the antibiotics
treatment. It would be worthwhile exploring in the fu-
ture how antibiotics effects vary between subjects and
depends on factors such as dosage, duration of the treat-
ment and type of antibiotics.
Conclusion
Several studies have addressed the temporal variability
or the technical variability (for example, induced by dif-
ferent DNA isolation methods or preservation tech-
niques) of the gut microbiome separately but none set
them in a broader context. Hence, these studies have so
far not disentangled the biological temporal variability
(like, for example, community shifts due to disease or
medication) from technical variability (for example, in-
duced by preservation conditions or insufficient stool
homogeneity).
In our study we provide the to date largest metage-
nomic data set of fecal samples collected over more than
two years. We addressed the aspects of comparing tech-
nical and temporal variability, finding that temporal vari-
ability within each subject’s gut microbiome was smaller
than that between subjects. Even in the context of 888
metagenomes, all time series samples could be recovered
using taxonomic abundances, as long as antibiotics did
not perturb the gut microbiome. The technical varia-
bility introduced by RNALater was small compared to
freezing, for both taxonomic and functional features,
and does not disrupt subject-specificity nor time point-
specificity of the gut microbiome. Thus, we suggest
RNALater as an alternative to freezing for the preserva-
tion of the fecal microbiome for metagenomic studies.
Material and methods
Sample collection
Fecal sample collection for time series
Informed consent to obtain time series samples of fecal
samples was obtained from seven healthy subjects in
Germany through the my.microbes project [45]. The
study protocol was approved by the EMBL Bioethics
Internal Advisory Board, and is in agreement with the
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in Heidelberg, Germany at the beginning of the study
and the mean age of the subjects upon enrollment was
34 ± 6 years. Among these subjects were five males
(Alien, Bugkiller, Peacemaker, Halbarad and Scavenger)
and two females (Daisy and Tigress). Subjects reported
themselves as healthy, if they did not undergo prescribed
medical treatment or showed any indication of disease
symptoms. Fecal samples were collected and conserved
under anaerobic conditions in a sealed bag, kept at −20°C
for short-term storage and stored at −80°C upon arrival in
the laboratory. The fecal samples were collected at days 0,
2, 7, 60, 392, 600 and 773 (sub-study 3) and are referred
to here as d0, d2, d7 and so on. One male subject (Alien)
contracted a bacterial infection and collected further sam-
ples after being hospitalized and receiving 2 g of ceftriax-
one. Ceftriaxone is an antibiotic with broad-spectrum
activity against Gram-positive and Gram-negative bacteria
that was administered parenterally over 4 days. The last
injection was two days before the first sampling time point
(d376) and further samples were then collected on the sub-
sequent days (d377, d378 and d380; sub-study 4). Additional
samples were taken starting one day after undergoing
bowel cleanse for routine colonoscopy (d630, d632 and d637;
sub-study 5). Figure 1 shows the study design in detail and
metadata and sequencing information are given in the
Additional file 1.
Fecal sample collection for method comparison
In parallel to the fresh frozen fecal samples, additional sam-
ples (1 g each) were collected from five subjects at time
point d7 and from three subjects at d392 (without ho-
mogenization) and were stored in 10 ml RNALater®
Stabilization Solution (Life Technologies GmbH, Darmstadt,
Germany). Short-term storage was either at +4 to 10°C or
at RT for one week (d7, sub-study 1) or at +4°C (d392, sub-
study 2) for 24 h and frozen at −80°C upon arrival in the
laboratory. At d392, each subject collected samples in trip-
licate, preserved in both RNALater and freshly frozen
(Figure 1).
Inclusion of published fecal metagenomes
Published metagenomes from MetaHIT [2,46,47] and
HMP [1] were included in our study to set our time
series in context of a large collection of metagenomes.
Sample processing and sequencing
DNA isolation from fecal samples
One milliliter of defrosted samples immersed in RNA-
Later was taken and diluted with sterile phosphate-
buffered saline and pelleted by centrifugation. Genomic
DNA was extracted from frozen or RNALater-preserved
fecal samples as previously described [48] using the
G’NOMEs kit (MP Biomedicals, Illkirch, France). Thefollowing minor modifications were made to the proto-
col: cell lysis/denaturation was performed (30 minutes,
55°C) before protease digestion was carried out over-
night (55°C). Mechanical lysis was followed by RNAse
digestion (50 μl, 30 minutes, 55°C). The purified DNA
was resuspended in TE buffer after final precipitation
for storage at −20°C.
Library preparation and metagenomic sequencing
Library generation and whole genome shotgun sequen-
cing of the fecal samples was carried out on the Illumina
HiSeq 2000/2500 (Illumina, San Diego, CA, USA) plat-
form as described in Zeller et al. [49]. All samples were
paired-end sequenced with 100 bp read lengths at the
Genomics Core Facility, European Molecular Biology
Laboratory, Heidelberg, to a sequencing depth of ap-
proximately 5 Gbp (see Additional file 1 for sequencing
results).
Data processing
Taxonomic profiling of fecal samples
Using MOCAT [50], a software package used to process
raw Illumina reads to generate taxonomic and functional
profiles (option screen with alignment length cutoff
45 and minimum 97% sequence identity), taxonomic
relative abundance profiles were generated by mapping
screened HQ reads from each metagenome to a database
consisting of 10 universal single-copy marker genes
extracted from 3,496 NCBI reference genomes and 263
human gut metagenomes that had previously been clus-
tered and linked by co-variance into mOTUs [29,51].
Quantification of mOTU linkage groups was performed
using MOCAT, but is also available as a standalone tool
at [29].
Functional profiling of fecal samples
Using MOCAT [50] (option screen with alignment
length cutoff 45 and minimum 95% sequence identity)
functional relative abundance profiles were generated by
first calculating gene abundance profiles by mapping
screened HQ (high quality) reads from each metage-
nome to an functionally annotated database consisting
of predicted genes from 263 human gut metagenomes
[29,49], and estimating each gene’s abundance as gene
length-normalized nucleotide counts of all reads that
matched the protein-coding region of the gene. And
second, for each functional feature, its abundance in the
metagenomic gene pool was estimated as the sum of the
relative abundances of all genes belonging to this family.
The genes were summarized into COGs [40], and
KEGG KOs, modules and pathways [41]. The metage-
nomic gene catalog had already been functionally anno-
tated to the KEGG database [48], and was additionally
annotated to different COGs by aligning the translated
Voigt et al. Genome Biology  (2015) 16:73 Page 10 of 12amino acid sequence of each gene to the eggNOG
(version 3) [40] database using BLAST (version 2.2.24)
[52] (maximum e-value 0.01) and then annotating the
genes using SmashCommunity (version 1.6) [53].Data analysis
For the statistical data analysis at the species level,
mOTU abundances were used [29] and samples were in-
cluded in the data analysis if they had more than 3,800
insert counts.Ecological indices
For the comparison of RNALater with fresh frozen feces
and time series samples with each other, mOTU abun-
dances [29] were used to calculate Shannon diversity
index, evenness and species richness. To standardize sam-
pling depth, richness, Shannon diversity index and even-
ness were assessed after rarefaction of the insert count
tables to 3,800 insert counts per sample. Differences were
assessed using the Wilcoxon test (unpaired) on the de-
viation from the mean of each subject. P-values ≤0.05
were considered statistically significant.Clustering
Principal coordinate analyses and complete linkage clus-
tering of Euclidean distances (Figure 2A) and Jensen-
Shannon divergence distances (Figure 5A) were performed
using the ape and ade4 R packages. The dendrograms
shown are based on Euclidean distance measurements on
the logged abundances (Figures 2B and 3B,C). Nearest
neighbors were determined to be the samples with the
smallest Euclidean distance (Figure 4; Additional files 2
and 3). Due to large differences in sequencing depth, the
metagenomes collected in this study and the HMP [1] and
MetaHIT [2,46,47] taxonomic data were only analyzed
after rarefaction to an insert count of 5,000 per sample.
All samples that passed these criteria were included in the
functional analysis.Two-way ANOVA
To observe taxonomic and functional-specific biases
introduced by RNALater preservation across all sub-
jects, a two-way ANOVA was performed for d7 and
d392 separately. Our setup was analogous to a pre-
vious analysis [36]. Relative species, COG, KO, mo-
dule and pathway abundances were arcsine square
root transformed (for variance stabilization) and only
features with a relative abundance of more than
0.01% in at least three samples were included. For
d392, the median value of the three replicates for each
feature was used.Data availability
The shotgun metagenomic sequencing data from this
study are available from the European Nucleotide Archive
(ENA) database [54], accession number ERP009422.
Description of additional data files
The following additional data are available with the on-
line version of this paper. Additional file 1 is a table
listing the metadata and sequencing information of the
analyzed samples. Additional file 5 is a table listing sta-
tistically significant taxonomic and functional features
resulting from the method comparison.Additional files
Additional file 1: Table S1. Overview of the metadata of the subjects
and sequencing information of the samples included.
Additional file 2: Figure S1. Nearest neighbor plot based on COGs.
Additional file 3: Figure S2. Nearest neighbor plot based on KOs.
Additional file 4: Figure S3. Comparison of technical, temporal and
between-subject variability based on functional profiles.
Additional file 5: Table S2. Overview of taxonomic and functional
features. The features include those above the horizontal black line in
Figure 3 and Additional file 4.
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